Aytu Biopharma, Inc. (NASDAQ:AYTU) Q1 2022 Earnings Conference Call November 16, 2021 4:30 PM ET Company Participants Josh Disbrow – Chairman and Chief Executive Officer Richard Eisenstadt – Chief Financial Officer Conference Call Participants Jennifer Kim – Cantor Fitzgerald Operator Good afternoon and thank you for joining us for the Aytu BioPharma First Quarter Fiscal 2022 Financial Results Call. With me this afternoon, our Aytu's Chairman and Chief Executive Officer, Josh Disbrow, and Chief Financial Of ...

Aytu Biopharma, Inc. (NASDAQ:AYTU) Q4 2021 Earnings Conference Call September 27, 2021 4:30 PM ET Company Participants Josh Disbrow - Chairman and CEO Richard Eisenstadt - CFO Conference Call Participants Jennifer Kim - Cantor Fitzgerald Vernon Bernardino - H.C. Wainwright Operator Good afternoon and thank you for joining us for the Aytu Biopharma Fourth Quarter and Full-Year Fiscal 2021 Financial Results Call. With me this afternoon are Aytu's Chairman and Chief Executive Officer, Josh Disbrow; and Chief ...

Aytu Biopharma, Inc. (NASDAQ:AYTU) Q3 2021 Earnings Conference Call May 17, 2021 4:30 PM ET Company Participants Joshua Disbrow - Chairman and CEO Richard Eisenstadt - CFO Conference Call Participants Jennifer Kim - Cantor Fitzgerald Operator Good afternoon and thank you for joining us today for the Aytu Biopharma Financial Results and Business Update Call for the Fiscal Third Quarter Ended March 31st, 2021. With me this afternoon are Aytu's Chairman and Chief Executive Officer, Josh Disbrow; and Chief Fina ...

Aytu BioScience, Inc. (NASDAQ:AYTU) Q2 2021 Earnings Conference Call February 11, 2021 4:30 PM ET Company Participants Joshua Disbrow - Chairman & CEO David Green - CFO, Secretary & Treasurer Conference Call Participants Vernon Bernardino - H.C. Wainwright & Co. Operator Good afternoon, and thank you for joining us for the Aytu BioScience Second Quarter Fiscal 2021 Business Update Call for the Quarter Ended December 31, 2020. With me this afternoon are Aytu's Chairman and Chief Executive Officer, Josh Disbr ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended: September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-38247 AYTU BIOSCIENCE, INC. (www.aytubio.com) Delaware 47-0883144 (State or other jurisdiction of incorporation or organization) (IRS Emp ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 333-146542 AYTU BIOSCIENCE, INC. (Exact Name of Registrant as Specified in Its Charter) 47-0883144 | --- | --- | |---------------------------|------------------------------------ ...